Bookmark and Share

2015 State of the School Address

Undaunted in Purpose, Resilient in Execution

On October 28, 2015, E. Albert Reece, MD, PhD, MBA, Vice President for Medical Affairs at the University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the University of Maryland School of Medicine (UM SOM), delivered his annual State of the School speech to a standing-room-only crowd.  The theme of this year’s State of the School address was Undaunted in Purpose, Resilient in Execution.

Sots2015 image
Watch the Complete Video:

2015 State of the School

View by Section: 

Part 1 - Opening Remarks & Vision 20/20  

Part 2 - Research

Part 3 - Research

Part 4 - Patient Care

Part 5 - Education

Part 6 - Outreach

Part 7 - Finance and Philanthropy

Download the 2014
SOTS Publication >>


Charge to Faculty and Staff Video >>


 “I know that I stand before an undaunted community this afternoon,” said Dean Reece. “I sometimes marvel at our resilience in face of inevitable challenges. Each day, we improve the trajectory of progress in science and medicine. For this reason, it is important that we set aside time each year to collectively celebrate our successes. This Address includes just a small sample of the collective progress that we have made over the past year.  These examples illustrate what happens when we set our sights on valiant outcomes, and not on temporary obstacles.”

Resilience has been necessary over the last few years, with sequestration and flat NIH funding adding to the already challenging task of securing grant funding. Yet UM SOM continues to grow in this area, earning $402.4 million in Research Grants and Contracts in FY 15, a nine percent increase. Contributing to this were numerous multi-million dollar grants, both from the National Institutes for Health (NIH) and from non-NIH funding sources such as the CDC, the Maryland Department of Health and Mental Hygiene, the Bill and Melinda Gates Foundation, and GlaxoSmithKline, with whom UM SOM researchers worked in testing a potential vaccine against the Ebola virus.


Learn More:

Web News Story >>